Supernus Pharmaceuticals
SUPN
#4394
Rank
S$2.36 B
Marketcap
$42.37
Share price
2.78%
Change (1 day)
6.37%
Change (1 year)

Earnings for Supernus Pharmaceuticals (SUPN)

Earnings in 2024 (TTM): S$0.12 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's current earnings are S$0.66 Billion. , an increase over its 2023 earnings that were of S$6.81 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Supernus Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 S$0.12 B1787.92%
2023 S$6.81 M-92.36%
2022 S$89.18 M-29.8%
2021 S$0.12 B-49.79%
2020 S$0.25 B12.99%
2019 S$0.22 B7.58%
2018 S$0.20 B54.9%
2017 S$0.13 B84.25%
2016 S$72.93 M202.27%
2015 S$24.12 M-462.04%
2014 -S$6.67 Million-94%
2013 -S$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.28 Billion-316.65%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.08 B 1,516.33%๐Ÿ‡บ๐Ÿ‡ธ USA
S$16.67 B 12,856.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$11.02 Billion-8,661.36%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.22 B 7,065.63%๐Ÿ‡บ๐Ÿ‡ธ USA
S$22.93 B 17,721.60%๐Ÿ‡บ๐Ÿ‡ธ USA